BETAAccess all features while we're in beta! Some features may become paid later.Got feedback? Reach us 👉

Loading ANIX charts…

Search ticker or company⌘K

ANIX

01Multicharts 02Comparables 03Price target

May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy

ANIX · Anixa Biosciences Inc fundamentals · vpside

vpside

⌘K

ANIXMarket cap $107M/Last filing 10-Q · 9 Sept 2026/ANIXMarket cap $107M/Last filing 10-Q · 9 Sept 2026/ANIXMarket cap $107M/Last filing 10-Q · 9 Sept 2026/ANIXMarket cap $107M/Last filing 10-Q · 9 Sept 2026/

Filings synced 13:22 · Prices: prior close 30 Oct

ANIX

Anixa Biosciences Inc

Nasdaq · Pharmaceutical preparations (SIC 2834) · FY ends 31 Oct

01Multicharts 02Comparables 03Price target

Add a metric37 metrics

Revenue, quarterly

$600000$400000$200000$0

vpside.com

Q1 ’18Q2 ’19Q3 ’20Q3 ’22Q4 ’23

Company filings · 10-K filed 10 Jan 2025 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

−1069.0%−1168.8 pp year on year

500%0%−500%−1000%−1500%

vpside.com

Q2 ’11Q4 ’11Q3 ’12Q1 ’13Q3 ’13

Company filings · 10-Q/A filed 20 Sept 2013 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$1M−6.5% year on year

$30M$20M$10M$0

vpside.com

Q4 ’20Q1 ’23Q2 ’24Q2 ’25Q3 ’26

Company filings · 10-Q filed 9 Sept 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$6M

$3M$0−$3M−$5M−$8M

vpside.com

Q1 ’16Q2 ’17Q3 ’18Q3 ’19Q4 ’20

Company filings · 10-K filed 4 Jan 2022 · TTM = last four quartersvpside.com

Chart 05 is empty

Chart 06 is empty

Fundamentals: company filings · Q4 = full year − nine months · TTM = last four quarters